Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes and Cardiovascular Disease: an Update
Rajaa Almourani, Bhavana Chinnakotla, Richa Patel, et al.
Current Diabetes Reports (2019) Vol. 19, Iss. 12
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
Dario Giugliano, Miriam Longo, Simona Signoriello, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 98
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
Cheng Han Ng, Kai En Chan, Yip Han Chin, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 3, pp. 565-574
Open Access | Times Cited: 64
Natural antioxidants in diabetes treatment and management: prospects of astaxanthin
Osman N. Kanwugu, Т. В. Глухарева, Irina Danilova, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 18, pp. 5005-5028
Closed Access | Times Cited: 60
The interplay between diabetes mellitus and menopause: clinical implications
Ιrene Lambrinoudaki, Stavroula Α. Paschou, Eleni Armeni, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 10, pp. 608-622
Closed Access | Times Cited: 54
Oxidative Stress Signaling Mediated Pathogenesis of Diabetic Cardiomyopathy
Zhaobing Tang, Peng Wang, Chao Dong, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 44
Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes
Melanie J. Davies, Heinz Drexel, François R. Jornayvaz, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 44
The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease
Yuan Lin, Te-Hsiung Wang, Ming‐Lung Tsai, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Development and validation of a deep-learning model to predict 10-year atherosclerotic cardiovascular disease risk from retinal images using the UK Biobank and EyePACS 10K datasets
Ehsan Vaghefi, David Squirrell, Song Yang, et al.
Cardiovascular Digital Health Journal (2024) Vol. 5, Iss. 2, pp. 59-69
Open Access | Times Cited: 12
The Role of Anthocyanin in Modulating Diabetic Cardiovascular Disease and Its Potential to Be Developed as a Nutraceutical
Syaifuzah Sapian, Izatus Shima Taib, Haliza Katas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1344-1344
Open Access | Times Cited: 26
Association of circadian rest-activity rhythms with cardiovascular disease and mortality in type 2 diabetes
Lulu Yang, Hongliang Feng, Jie Chen, et al.
Diabetes Research and Clinical Practice (2023) Vol. 197, pp. 110262-110262
Open Access | Times Cited: 13
Age- and sex-specific effects of a long-term lifestyle intervention on body weight and cardiometabolic health markers in adults with prediabetes: results from the diabetes prevention study PREVIEW
Ruixin Zhu, Ionut Craciun, Jan Bernhards-Werge, et al.
Diabetologia (2022) Vol. 65, Iss. 8, pp. 1262-1277
Open Access | Times Cited: 20
Treatment of diabetic complications: do flavonoids holds the keys?
Rishabh Chalotra, Tanya Gupta, Shivani Chib, et al.
Critical Reviews in Food Science and Nutrition (2023) Vol. 64, Iss. 30, pp. 11091-11112
Closed Access | Times Cited: 12
Cardiovascular and renal outcomes of GLP-1 receptor agonists vs. DPP-4 inhibitors and basal insulin in type 2 diabetes mellitus: A systematic review and meta-analysis
Marc Evans, Paul Kuodi, Chisom Joyqueenet Akunna, et al.
Diabetes and Vascular Disease Research (2023) Vol. 20, Iss. 6
Open Access | Times Cited: 11
Effective protective mechanisms of HO-1 in diabetic complications: a narrative review
Jingjing Zhang, Ping Ni, Yi Song, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Development of a sodium hyaluronate-enriched therapeutic formulation with stevia glycoside and mogroside V for the comprehensive management of diabetes and its complications
Pengyu Lei, Hou‐Yong Yu, Tao Jiang, et al.
International Journal of Biological Macromolecules (2025) Vol. 293, pp. 139487-139487
Closed Access
Sequence of episodic memory-related behavioral and brain-imaging abnormalities in type 2 diabetes
Bo Hu, Ying Yu, Xiaofeng Yu, et al.
Nutrition and Diabetes (2025) Vol. 15, Iss. 1
Open Access
Prognostic value of the neutrophil to lymphocyte ratio for cardiovascular diseases: research progress
Xinyue Zhang, Dongyang Li, Yanwei Du
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1170-1177
Closed Access
Impact of diabetes on risk of major adverse cardiovascular events associated with lipoprotein(a) levels in patients with established atherosclerotic cardiovascular disease
Kyuwoong Kim, Min Kyoung Kim, Jiye Han, et al.
European Journal of Preventive Cardiology (2025)
Closed Access
The management of cardiovascular risk in people with diabetes: Insights from an audit of health services providing diabetes care
Ella Zomer, Stella Talic, Ahmad Reza Pourghaderi, et al.
Diabetes Research and Clinical Practice (2025), pp. 112121-112121
Closed Access
Therapeutic tailored approach in patients with diabetes, cardiovascular and renal comorbidities: a cardiologist view
Ermanno Nardi, Maria Prastaro, Ciro Santoro, et al.
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 104033-104033
Closed Access
Dihydromyricetin Improves Endothelial Dysfunction in Diabetic Mice via Oxidative Stress Inhibition in a SIRT3-Dependent Manner
Yuyun Hua, Yue Zhang, Weiwei Gong, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6699-6699
Open Access | Times Cited: 31
Inhibiting Rev-erbα-mediated ferroptosis alleviates susceptibility to myocardial ischemia-reperfusion injury in type 2 diabetes
Qin Huang, Hao Tian, Liqun Tian, et al.
Free Radical Biology and Medicine (2023) Vol. 209, pp. 135-150
Open Access | Times Cited: 10
The Predictive Effect of Negative Psychological Emotions of Anxiety and Depression on the Poor Prognosis of CHD Patients with Stent Implantation and the Improvement of Clinical Intervention Measures
Guoxing Li, Yuhuan Tian, Qiumin Zhang, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 15
Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review
Alexandros L. Liarakos, Anastasios Tentolouris, Alexandros Kokkinos, et al.
Journal of Diabetes and its Complications (2022) Vol. 37, Iss. 2, pp. 108390-108390
Closed Access | Times Cited: 15
A meta-analysis on the prevalence, associated factors and diagnostic methods of mental stress induced myocardial ischemia
Lijun Zhang, Yanping Bao, Xi Wang, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top